Dr. Giulia Midena graduated in Medicine and Surgery from Campus Bio-Medico University of Rome in 2015 and completed her residency in Ophthalmology in 2020 at the Catholic University of the Sacred Heart in Rome. In 2020, she undertook a fellowship at the University Hospital of Padova, focusing on degenerative and oncological chorioretinal diseases and orbital disorders. She earned the FEBO title in 2021 and completed a PhD in Molecular Medicine in 2024 at the University of Padova, with a project on aqueous humor biomarkers in uveal melanoma. Since 2020, she has been a researcher at the G.B. Bietti Foundation for Ophthalmology, IRCCS, in Rome. Her main interests include conservative therapies for ocular tumors, ocular toxicology, chorioretinal diseases, and diagnostic biomarkers in ocular fluids. She also explores AI applications in retinal multimodal imaging. Dr. Midena is a member of ARVO, EURETINA, and the Italian Society of the Retina. She is the author of over 40 peer-reviewed publications and serves as a reviewer for leading journals such as Ophthalmology, IOVS, Cancers, and Scientific Reports. She has presented extensively at conferences and received awards including the ARVO Travel Grant (2013) and the SICOP Frezzotti Award (2017).